Brind.
  1. Citi's conference is held in Boston, MA.
  2. Compass Therapeutics, Inc. participated in Citi's Biopharma Back to School Conference in Boston.

Compass Therapeutics, Inc. received an 'Outperform' rating from Raymond James following Q2 results, related to their drug Tovecimig targeting Delta-like ligand 4.

2 reports, 2 independent Updated Aug 20
Gone quiet Reached 2 outlets in its first 24 hours
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Compass Therapeutics, Inc. received an 'Outperform' rating from Raymond James following Q2 results, related to their drug Tovecimig targeting Delta-like ligand 4.

Who's involved

What this event is mainly about
Raymond James

Keep exploring

Part of

Compass Therapeutics, Inc. participated in Citi's Biopharma Back to School Conference in Boston. All 1 developments

Within Citi's conference is held in Boston, MA.

The entities involved

Coverage

Newest first; wire copies grouped
  • Insider MonkeyCompass Therapeutics (CMPX) Rated ‘Outperform’ amid Clinical Pipeline Development Compass Therapeutics, Inc. (NASDAQ:CMPX) is one of the top multibagger penny stocks to buy, according to analysts. On
  • Simply Wall St.Compass Therapeutics And 2 Other Promising Penny Stocks To Consider As the U.S. stock market continues its rally, with major indices like the S&P 500 and Nasdaq reaching new all-time highs, investors